Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: Effect of preemptive therapy

Transplantation Proceedings

Volumn 44, Issue 9, 2012, Pages 2660-2662

  Mendez Eirin, E ^a   Paniagua Martin M J ^a   Marzoa Rivas, R ^a   Barge Caballero, E ^a   Grille Cancela, Z ^a   Canizares A ^a   Naya Leira, C ^a   Gargallo Fernandez P ^a   Castro Beiras, A ^a   Crespo Leiro, M ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; BLOOD TRANSFUSION; CARDIAC GRAFT REJECTION; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; VIRUS LOAD;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; CYTOMEGALOVIRUS INFECTIONS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84869029977     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.09.035     Document Type: Conference Paper

References (16)

1. D. Abate, M. Fiscon, A. Saldan Human Cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection J Clin Microbiol 50 2012 1974
2. J.F. Delgado, N. Manito, L. Almenar Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study Transpl Infect Dis 13 2011 136
3. J. Segovia, J.L. Rodriguez-Lambert, M.G. Crespo-Leiro A randomized Multicenter comparison of Basiliximab and muromonab (OKT3) heart transplantation: SIMCOR study Transplantation 81 2006 1542
4. S. Gupta, J.D. Mitchell, D.W. Markham High incidence of cytomegalovirus disease in D+/R- heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxis J Heart Lung Transplant 27 2008 536
5. P.A. Andrews, V.C. Emery, C. Newstead Summary of the British Transplantation Society guidelines for the prevention and management of CMV disease after solid organ transplantation Transplantation 92 2011 1181
6. M.J. Paniagua, M.G. Crespo-Leiro, L. De Ia Fuente Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days: intravenous ganciclovir Transplant Proc 34 2002 69
7. D. Van De Beek, W.K. Kremers, J.L. Del Pozo Effect of infectious diseases on outcome after heart transplant Mayo Clin Proc 83 2008 304
8. M.T. Grattan, C.E. Moreno-Cabral, V.A. Starnes Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561
9. J.A. Graham, R.A. Wilkinson, T. Hirohashi Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway Am J Transplant 9 2009 2479
10. A.A. Kocher, N. Bonaros, D. Dunkler Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients J Heart Lung Transplant 22 2003 250
11. G.J. Boland, C. Ververs, R.J. Hene Early detection of primary cytomegalovirus infection after heart and kidney transplantation and the influence of hyperimmune globulin prophylaxis Transplant 6 1993 34
12. G. Gerna, D. Zipeto, M. Parea Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia J Infect Dis 164 1991 488
13. P. Grossi, M.G. Revello, L. Minoli Three-year experience with human cytomegalovirus infections in heart transplant recipients J Heart Transplant 9 1990 712
14. P.K. Koskinen, M.S. Nieminen, S.P. Mattila The correlation between symptomatic CMV infection and CMV antigenemia in heart allograft recipients Transplantation 55 1993 547
15. J. Niubo, J.L. Perez, J.T. Martinez-Lacasa Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients Diagn Microbiol Infect Dis 24 1996 19
16. D.R. Syndman, A.P. Limaye, L. Potena Update and review: state-of-the art management of cytomegalovirus infection and disease following thoracic organ transplantation Transplant Proc 43 3 Suppl 2011 S1